Henderson Jane sold APGE
November 25, 2025 · Form 4 insider transaction
Henderson Jane sold 1,500 shares of Apogee Therapeutics, Inc. at $70.00 per share, a transaction worth $105.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,500
Price
$70.00
Total value
$105.0K
InsiderHenderson Jane
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateNovember 25, 2025
Filing dateNovember 28, 2025
Shares owned after196,371
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on September 27, 2024.